Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bustamante

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Annals of the Rheumatic Diseases|August 1, 2018
Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritisMarta F Bustamante, Patricia G Oliveira, Ricard Garcia-Carbonell, et al.
Journal of Neuroimmunology|September 6, 2011
IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosisS Malhotra, C Morcillo-Suárez, D Brassat, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 8, 2015
Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-βMarta F Bustamante, Carlos Morcillo-Suárez, Sunny Malhotra, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|May 4, 2021
Type 1 Diabetes Care in Mexico: An Analysis of the RENACED-DT1 National RegistryRaquel N Faradji-Hazán, Marisol Valenzuela-Lara, Ana P Díaz-Barriga Menchaca, et al.
Diabetes Research and Clinical Practice|September 6, 2021
Glycemic control, treatment and complications in patients with type 1 diabetes amongst healthcare settings in MexicoNeftali Eduardo Antonio-Villa, Aili García-Tuomola, Paloma Almeda-Valdes, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Annals of the Rheumatic Diseases|August 1, 2018
Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritisMarta F Bustamante, Patricia G Oliveira, Ricard Garcia-Carbonell, et al.
Journal of Neuroimmunology|September 6, 2011
IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosisS Malhotra, C Morcillo-Suárez, D Brassat, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 8, 2015
Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-βMarta F Bustamante, Carlos Morcillo-Suárez, Sunny Malhotra, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|May 4, 2021
Type 1 Diabetes Care in Mexico: An Analysis of the RENACED-DT1 National RegistryRaquel N Faradji-Hazán, Marisol Valenzuela-Lara, Ana P Díaz-Barriga Menchaca, et al.
Diabetes Research and Clinical Practice|September 6, 2021
Glycemic control, treatment and complications in patients with type 1 diabetes amongst healthcare settings in MexicoNeftali Eduardo Antonio-Villa, Aili García-Tuomola, Paloma Almeda-Valdes, et al.
Pageof 4